ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
T60-161,Citalopram,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse",NA
T60-161,Codeine (component of Apo-Acetaco #1),"CYP2D6OPRM1",Usual prescribing considerations apply,NA
T60-161,folic acid,NA,NO,NA
T60-161, prednisone,NA,NO,NA
T60-161, methotrexate,NA,NO,NA
T60-161, gabapentin,NA,NO,NA
T60-161, acetaminophen (component of Apo-Acetaco #1),NA,NO,NA
